Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland

por Kluz, Tomasz, Jasiewicz, Andrzej, Marczyk, Elżbieta, Jach, Robert, Jakubowska, Anna, Lubiński, Jan, Narod, Steven A., Gronwald, Jacek
Publicado 2018

Pathological complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients

por Byrski, Tomasz, Huzarski, Tomasz, Dent, Rebecca, Marczyk, Elzbieta, Jasiowka, Marek, Gronwald, Jacek, Jakubowicz, Jerzy, Cybulski, Cezary, Wisniowski, Rafal, Godlewski, Dariusz, Lubinski, Jan, Narod, Steven A
Publicado 2015

Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer

por Byrski, Tomasz, Dent, Rebecca, Blecharz, Pawel, Foszczynska-Kloda, Malgorzata, Gronwald, Jacek, Huzarski, Tomasz, Cybulski, Cezary, Marczyk, Elzbieta, Chrzan, Robert, Eisen, Andrea, Lubinski, Jan, Narod, Steven A
Publicado 2012